J. Clark
Epidemiology · New England Journal of Medicine · 2003–2021
A researcher in the Science corpus: 12 papers; trusts 2 researchers and is trusted by 3 researchers here, as inferred from the citation graph.
Subfields
- Epidemiology — 68 citations into it; #842 of 2,148 by trust here, #240 by citations
- Hepatology — 36 citations into it; #42 of 151 by trust here, #24 by citations
- Pathology and Forensic Medicine — 20 citations into it; #152 of 414 by trust here, #260 by citations
Whom J. Clark trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Who trusts J. Clark overall
Papers from J. Clark's perspective
Ordered by how strongly the researchers J. Clark trusts endorse each paper. Same corpus, a different order for every researcher.
- Clinical Features and Natural History of Nonalcoholic Steatosis Syndromes (Seminars in liver disease (Print))
- Frequency and outcomes of liver transplantation for nonalcoholic steatohepatitis in the United States. (Gastroenterology)
- Prevalence of and Risk Factors for Hepatic Steatosis in Northern Italy (Annals of Internal Medicine)
- Liver fibrosis in overweight patients. (Gastroenterology)
- The prevalence and etiology of elevated aminotransferase levels in the United States (American Journal of Gastroenterology)
- AGA technical review on nonalcoholic fatty liver disease. (Gastroenterology)
- The epidemiology of nonalcoholic fatty liver disease: a global perspective. (Seminars in liver disease (Print))
- Expanding the natural history of nonalcoholic steatohepatitis: from cryptogenic cirrhosis to hepatocellular carcinoma. (Gastroenterology)
- Nonalcoholic fatty liver disease: predictors of nonalcoholic steatohepatitis and liver fibrosis in the severely obese. (Gastroenterology)
- Nonalcoholic steatohepatitis (Current treatment options in gastroenterology)
Their papers
- Prospective Study of Outcomes in Adults with Nonalcoholic Fatty Liver Disease (2021) — 821 citations
- Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial (2014) — 2,063 citations
- Prevalence of nonalcoholic fatty liver disease in the United States: the Third National Health and Nutrition Examination Survey, 1988-1994. (2013) — 796 citations
- Cardiovascular effects of intensive lifestyle intervention in type 2 diabetes. (2013) — 1,723 citations
- Comparative Effectiveness of Weight-Loss Interventions in Clinical Practice (2011) — 762 citations
- Diagnostic accuracy and reliability of ultrasonography for the detection of fatty liver: A meta‐analysis (2011) — 1,498 citations
- Effect of Vitamin E or Metformin for Treatment of Nonalcoholic Fatty Liver Disease in Children and Adolescents (2011) — 1,028 citations
- Pioglitazone, Vitamin E, or Placebo for Nonalcoholic Steatohepatitis (2010) — 3,032 citations
- The epidemiology of nonalcoholic fatty liver disease: a global perspective. (2008) — 782 citations
- Reduction in Weight and Cardiovascular Disease Risk Factors in Individuals With Type 2 Diabetes (2007) — 1,589 citations
- The Epidemiology of Nonalcoholic Fatty Liver Disease in Adults (2006) — 805 citations
- The prevalence and etiology of elevated aminotransferase levels in the United States (2003) — 1,413 citations